Ticker >

Wanbury share price

Wanbury Ltd.

NSE: WANBURY BSE: 524212 SECTOR: Pharmaceuticals & Drugs  15k   19   1

147.15
-3.60 (-2.39%)
BSE: 16 Apr 04:01 PM

Price Summary

Today's High

₹ 153.3

Today's Low

₹ 147.15

52 Week High

₹ 177.4

52 Week Low

₹ 34.06

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

481.85 Cr.

Enterprise Value

542.09 Cr.

No. of Shares

3.27 Cr.

P/E

20.65

P/B

36.08

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  4.08

CASH

3.89 Cr.

DEBT

64.14 Cr.

Promoter Holding

39.79 %

EPS (TTM)

₹  7.13

Sales Growth

-2.26%

ROE

0 %

ROCE

17.68%

Profit Growth

-112.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-2.26%
3 Year10.79%
5 Year6.13%

Profit Growth

1 Year-112.76%
3 Year-154.43%
5 Year10.87%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year17.68%
3 Year84.06%
5 Year96.8%

Debt/Equity

-7.1204

Price to Cash Flow

24.34

Interest Cover Ratio

0.519164609976815

CFO/PAT (5 Yr. Avg.)

1.53802557569789

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 39.79 76.74
Sep 2023 39.8 76.74
Jun 2023 39.84 76.74
Mar 2023 39.84 76.74
Dec 2022 39.84 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 84.059464008064% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of -124.667963289427 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.53802557569789.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 18.2136954726558.

 Limitations

  • The company has shown a poor profit growth of -154.431578738808% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.7862899098743% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has contingent liabilities of 1071.7438 Cr.
  • Tax rate is low at -1.05961037446047.
  • The company has a low EBITDA margin of 2.41143610811724% over the past 5 years.
  • The company has negative book value.
  • Promoter pledging is high as 76.74%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 125.78 132.98 146.29 144.46 145.5
Total Expenditure 119.32 118.81 132.94 127.12 124.35
Operating Profit 6.46 14.16 13.35 17.34 21.15
Other Income 0.26 -2.06 0.62 0.76 0.69
Interest 6.63 7.52 5.79 7.67 8.26
Depreciation 3.13 3.07 3.19 3.24 3.32
Exceptional Items 0 -0.59 0 0 0
Profit Before Tax -3.05 0.92 4.99 7.19 10.26
Tax 0.23 -0.1 0.3 -0.18 -0.02
Profit After Tax -3.28 1.02 4.69 7.36 10.27
Adjusted EPS (Rs) -1 0.31 1.43 2.25 3.14

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 391.37 367.45 392.52 511.19 499.65
Total Expenditure 378.01 389.07 376.85 479.45 476.57
Operating Profit 13.37 -21.62 15.67 31.73 23.08
Other Income 11.5 46.2 4.75 5.09 1.01
Interest 39.88 32.87 23.07 20.61 21.39
Depreciation 9.97 9.68 9.75 11.45 12.38
Exceptional Items 0 82.64 0 76.37 -0.59
Profit Before Tax -24.99 64.67 -12.41 81.13 -10.29
Tax -0.14 0.21 0.2 -0.35 0.11
Net Profit -24.85 64.46 -12.61 81.47 -10.4
Adjusted EPS (Rs.) -10.48 25.79 -5.04 24.94 -3.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 23.72 25 25.02 32.67 32.71
Total Reserves -207.31 -142.83 -155.67 -30.48 -39.96
Borrowings 123.03 99.54 71.99 0 0
Other N/C liabilities 7.33 8.2 12.44 10.56 10.81
Current liabilities 334.48 283.89 328.19 332.62 293.19
Total Liabilities 281.25 273.8 281.97 345.37 296.75
Assets
Net Block 172.36 163.9 167.38 167.11 167.11
Capital WIP 8.97 13.89 11.01 2.35 1.61
Intangible WIP 0 0 0 0 0
Investments 0.02 0.01 0.01 0.01 0.01
Loans & Advances 3.11 3.8 3.4 3.8 5.03
Other N/C Assets 0.07 0.1 4.2 2.41 2.46
Current Assets 96.72 92.11 95.95 169.69 120.54
Total Assets 281.25 273.8 281.97 345.37 296.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -24.99 64.67 -12.41 81.13 -10.29
Adjustment 42.9 -41.41 33.22 -43.68 37.01
Changes in Assets & Liabilities 11.88 20.9 -3 3.24 -6.75
Tax Paid -0.06 -0.03 -1.13 -0.16 -0.17
Operating Cash Flow 29.73 44.13 16.68 40.52 19.8
Investing Cash Flow -3.07 63.66 8.04 0.59 -8.84
Financing Cash Flow -26.78 -107.87 -17.39 -28.58 -31.99
Net Cash Flow -0.13 -0.09 7.34 12.53 -21.03

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 39.84 39.84 39.84 39.80 39.79
expert chemicals (india) ... 30.59 30.59 30.59 30.56 30.56
kingsbury investments inc... 9.25 9.25 9.25 9.24 9.23
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 60.16 60.16 60.16 60.20 60.21
authum investment and inf... 3.87 - 3.87 3.86 3.86
bakliwal fincom private l... 2.82 - 2.82 2.82 2.82
east eight six advisors l... 1.41 - 1.41 1.41 1.41
elizabeth mathew . - - - - 4.59
investor education and pr... 1.03 - 1.03 1.03 1.03
llp 1.46 - - 1.45 1.55
magnum equifin private li... 1.53 - 1.53 1.53 1.53
milan manharkant ganatra 1.08 - 1.08 1.08 1.08
suresh bhatia 2.35 - 2.35 2.35 2.35
varalakshmi veldi . - - 1.36 1.41 1.41
vijay k choraria 2.82 - 2.82 2.82 2.82
yanni global (opc) privat... 1.30 - 1.30 1.30 1.30
elizabeth mathew 5.64 - 5.64 5.64 -
ganita technologies and s... - - 1.25 - -
investor education and pr... - 1.03 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Wanbury Stock Price Analysis and Quick Research Report. Is Wanbury an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Wanbury and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Wanbury cash from the operating activity was Rs 19.7972 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Wanbury has a Debt to Equity ratio of -7.1204 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Wanbury , the EPS growth was -112.74401709573 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Wanbury has OPM of 4.61872174129371 % which is a bad sign for profitability.
     
  • ROE: Wanbury have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Wanbury is Rs 150.8. One can use valuation calculators of ticker to know if Wanbury share price is undervalued or overvalued.
Last Updated on:
Brief about Wanbury
X